IGHG1 report

I. Expression across cell types

II. Expression across tissues

sc-RNAseq data

Insufficient scRNA-seq data for expression of IGHG1 at tissue level.

III. Associated gene sets

GO_0002250Biological processadaptive immune response
GO_0050853Biological processB cell receptor signaling pathway
GO_0006958Biological processcomplement activation, classical pathway
GO_0001788Biological processantibody-dependent cellular cytotoxicity
GO_0097278Biological processcomplement-dependent cytotoxicity
GO_0019731Biological processantibacterial humoral response
GO_0005615Cellular componentextracellular space
GO_0042571Cellular componentimmunoglobulin complex, circulating
GO_0071735Cellular componentIgG immunoglobulin complex
GO_0072562Cellular componentblood microparticle
GO_0070062Cellular componentextracellular exosome
GO_0005576Cellular componentextracellular region
GO_0005886Cellular componentplasma membrane
GO_0034987Molecular functionimmunoglobulin receptor binding
GO_0003823Molecular functionantigen binding
GO_0034988Molecular functionFc-gamma receptor I complex binding
GO_0005515Molecular functionprotein binding

IV. Literature review

[source]
Gene nameIGHG1
Protein nameImmunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)
Immunoglobulin heavy constant gamma 1
Synonyms
DescriptionFUNCTION: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens . The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen . Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells. .

AccessionsP01857
ENST00000631402.1
ENST00000631539.1 [P01857-2]
ENST00000390542.6
A0A0A0MS07
ENST00000631466.1 [P01857-1]
ENST00000390548.6 [P01857-2]
ENST00000390549.6 [P01857-1]